Form 8-K - Current report:
SEC Accession No. 0001829126-26-001885
Filing Date
2026-03-03
Accepted
2026-03-03 17:00:36
Documents
14
Period of Report
2026-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neonctechnologies_8k.htm   iXBRL 8-K 30657
2 EXHIBIT 4.1 neonctechnologies_ex4-1.htm EX-4.1 89220
3 EXHIBIT 10.1 neonctechnologies_ex10-1.htm EX-10.1 172338
  Complete submission text file 0001829126-26-001885.txt   509791

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cik0001979414-20260225.xsd EX-101.SCH 3044
5 XBRL LABEL FILE cik0001979414-20260225_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE cik0001979414-20260225_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT neonctechnologies_8k_htm.xml XML 3337
Mailing Address 23975 PARK SORRENTO SUITE 205 CALABASAS CA 91302
Business Address 23975 PARK SORRENTO SUITE 205 CALABASAS CA 91302 310 663 7831
NEONC TECHNOLOGIES HOLDINGS, INC. (Filer) CIK: 0001979414 (see all company filings)

EIN.: 921954864 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42567 | Film No.: 26716000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)